Lymphoid chemokines in the CNS

Journal of Neuroimmunology

Volumn 224, Issue 1-2, 2010, Pages 56-61

  Lalor, Stephen J ^a   Segal, Benjamin M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Chemokines; Experimental autoimmune encephalomyelitis; Lymphoid neogenesis; Multiple sclerosis; Neuroborreliosis; Primary CNS lymphoma

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR3; CXCL13 CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SECONDARY LYMPHOID TISSUE CHEMOKINE; AUTACOID; CHEMOKINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNITY; B CELL LYMPHOMA; BORRELIA BURGDORFERI; BRAIN LEUKEMIA; BRAIN LYMPHOMA; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; DEMYELINATION; HUMAN; IMMUNOSURVEILLANCE; LYME DISEASE; LYMPHOCYTIC INFILTRATION; LYMPHOID TISSUE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; CENTRAL NERVOUS SYSTEM DISEASE; HOMEOSTASIS; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; CHEMOKINES; HOMEOSTASIS; HUMANS; INFLAMMATION MEDIATORS; LYMPHOCYTES;

EID: 77955090750     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.05.017     Document Type: Article

References (66)

1. Aloisi F., Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 2006, 6:205-217.
2. Alt C., Laschinger M., Engelhardt B. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 2002, 32:2133-2144.
3. Ansel K., McHeyzer-Williams L., Ngo V., McHeyzer-Williams M., Cyster J. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J. Exp. Med. 1999, 190:1123-1134.
4. Axtell R., Steinman L. Gaining entry to an uninflamed brain. Nat. Immunol. 2009, 10:453-455.
5. Bagaeva L., Rao P., Powers J., Segal B. CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis. J. Immunol. 2006, 176:7676-7685.
6. Biber K., Sauter A., Brouwer N., Copray S., Boddeke H. Ischemia-induced neuronal expression of the microglia attracting chemokine Secondary Lymphoid-tissue Chemokine (SLC). Glia 2001, 34:121-133.
7. Booss J., Esiri M.M., Tourtellotte W.W., Mason D.Y. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J. Neurol. Sci. 1983, 62:219-232.
8. Buonamici S., Trimarchi T., Ruocco M., Reavie L., Cathelin S., Mar B., Klinakis A., Lukyanov Y., Tseng J., Sen F., Gehrie E., Li M., Newcomb E., Zavadil J., Meruelo D., Lipp M., Ibrahim S., Efstratiadis A., Zagzag D., Bromberg J., Dustin M., Aifantis I. CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia. Nature 2009, 459:1000-1004.
9. Castillo J., Dávalos A., Naveiro J., Noya M. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 1996, 27:1060-1065.
10. Chen S., Leach M., Chen Y., Cai X., Sullivan L., Wiekowski M., Dovey-Hartman B., Zlotnik A., Lira S. Central nervous system inflammation and neurological disease in transgenic mice expressing the CC chemokine CCL21 in oligodendrocytes. J. Immunol. 2002, 168:1009-1017.
11. Columba-Cabezas S., Serafini B., Ambrosini E., Aloisi F. Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation. Brain Pathol. 2003, 13:38-51.
12. Columba-Cabezas S., Griguoli M., Rosicarelli B., Magliozzi R., Ria F., Serafini B., Aloisi F. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein. J. Neuroimmunol. 2006, 179:76-86.
13. Corcione A., Casazza S., Ferretti E., Giunti D., Zappia E., Pistorio A., Gambini C., Mancardi G., Uccelli A., Pistoia V. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc. Natl Acad. Sci. USA 2004, 101:11064-11069.
14. Cyster J. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J. Exp. Med. 1999, 189:447-450.
15. de Jong E., Dijkstra I., Hensens M., Brouwer N., van Amerongen M., Liem R., Boddeke H., Biber K. Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion. J. Neurosci. 2005, 25:7548-7557.
16. Dijkstra I., Hulshof S., van der Valk P., Boddeke H., Biber K. Cutting edge: activity of human adult microglia in response to CC chemokine ligand 21. J. Immunol. 2004, 172:2744-2747.
17. Dijkstra I., de Haas A., Brouwer N., Boddeke H., Biber K. Challenge with innate and protein antigens induces CCR7 expression by microglia in vitro and in vivo. Glia 2006, 54:861-872.
18. Festa E., Hankiewicz K., Kim S., Skurnick J., Wolansky L., Cook S., Cadavid D. Serum levels of CXCL13 are elevated in active multiple sclerosis. Mult. Scler. 2009, 15:1271-1279.
19. Fischer L., Korfel A., Pfeiffer S., Kiewe P., Volk H., Cakiroglu H., Widmann T., Thiel E. CXCL13 and CXCL12 in central nervous system lymphoma patients. Clin. Cancer Res. 2009, 15:5968-5973.
20. Förster R., Mattis A., Kremmer E., Wolf E., Brem G., Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996, 87:1037-1047.
21. Giunti D., Borsellino G., Benelli R., Marchese M., Capello E., Valle M., Pedemonte E., Noonan D., Albini A., Bernardi G., Mancardi G., Battistini L., Uccelli A. Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. J. Leukoc. Biol. 2003, 73:584-590.
22. Halle S., Dujardin H., Bakocevic N., Fleige H., Danzer H., Willenzon S., Suezer Y., Hämmerling G., Garbi N., Sutter G., Worbs T., Förster R. Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells. J. Exp. Med. 2009, 206:2593-2601.
23. Hickey W., Hsu B., Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 1991, 28:254-260.
24. Hintzen R., Fiszer U., Fredrikson S., Rep M., Polman C., van Lier R., Link H. Analysis of CD27 surface expression on T cell subsets in MS patients and control individuals. J. Neuroimmunol. 1995, 56:99-105.
25. Hjelmström P. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J. Leukoc. Biol. 2001, 69:331-339.
26. Junt T., Fink K., Förster R., Senn B., Lipp M., Muramatsu M., Zinkernagel R., Ludewig B., Hengartner H. CXCR5-dependent seeding of follicular niches by B and Th cells augments antiviral B cell responses. J. Immunol. 2005, 175:7109-7116.
27. Kivisäkk P., Mahad D., Callahan M., Trebst C., Tucky B., Wei T., Wu L., Baekkevold E., Lassmann H., Staugaitis S., Campbell J., Ransohoff R. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc. Natl Acad. Sci. USA 2003, 100:8389-8394.
28. Kivisäkk P., Mahad D., Callahan M., Sikora K., Trebst C., Tucky B., Wujek J., Ravid R., Staugaitis S., Lassmann H., Ransohoff R. Expression of CCR7 in multiple sclerosis: implications for CNS immunity. Ann. Neurol. 2004, 55:627-638.
29. Krumbholz M., Theil D., Cepok S., Hemmer B., Kivisäkk P., Ransohoff R., Hofbauer M., Farina C., Derfuss T., Hartle C., Newcombe J., Hohlfeld R., Meinl E. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 2006, 129:200-211.
30. Krumbholz M., Theil D., Steinmeyer F., Cepok S., Hemmer B., Hofbauer M., Farina C., Derfuss T., Junker A., Arzberger T., Sinicina I., Hartle C., Newcombe J., Hohlfeld R., Meinl E. CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions. J. Neuroimmunol. 2007, 190:72-79.
31. Krumbholz M., Meinl I., Kümpfel T., Hohlfeld R., Meinl E. Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology 2008, 71:1350-1354.
32. Langer-Gould A., Atlas S., Green A., Bollen A., Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J. Med. 2005, 353:375-381.
33. Legler D., Loetscher M., Roos R., Clark-Lewis I., Baggiolini M., Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 1998, 187:655-660.
34. Magliozzi R., Columba-Cabezas S., Serafini B., Aloisi F. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2004, 148:11-23.
35. Magliozzi R., Howell O., Vora A., Serafini B., Nicholas R., Puopolo M., Reynolds R., Aloisi F. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007, 130:1089-1104.
36. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol. Today 1999, 20:254-257.
37. McMahon E., Bailey S., Castenada C., Waldner H., Miller S. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 2005, 11:335-339.
38. Moser B., Schaerli P., Loetscher P. CXCR5(+) T cells: follicular homing takes center stage in T-helper-cell responses. Trends Immunol. 2002, 23:250-254.
39. Moyron-Quiroz J., Rangel-Moreno J., Kusser K., Hartson L., Sprague F., Goodrich S., Woodland D., Lund F., Randall T. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat. Med. 2004, 10:927-934.
40. Müller G., Lipp M. Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking. Microcirculation 2003, 10:325-334.
41. Narayan K., Dail D., Li L., Cadavid D., Amrute S., Fitzgerald-Bocarsly P., Pachner A. The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis. Ann. Neurol. 2005, 57:813-823.
42. Noor S., Habashy A., Nance J., Clark R., Nemati K., Carson M., Wilson E. CCR7 dependent immunity during acute Toxoplasma gondii infection. Infect. Immun. 2010, 78:2257-2263.
43. Pashenkov M., Söderström M., Link H. Secondary lymphoid organ chemokines are elevated in the cerebrospinal fluid during central nervous system inflammation. J. Neuroimmunol. 2003, 135:154-160.
44. Ramesh G., Borda J., Gill A., Ribka E., Morici L., Mottram P., Martin D., Jacobs M., Didier P., Philipp M. Possible role of glial cells in the onset and progression of Lyme neuroborreliosis. J. Neuroinflammation 2009, 6:23.
45. Rappert A., Biber K., Nolte C., Lipp M., Schubel A., Lu B., Gerard N., Gerard C., Boddeke H., Kettenmann H. Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl- current and chemotaxis in murine microglia. J. Immunol. 2002, 168:3221-3226.
46. Rupprecht T., Elstner M., Weil S., Pfister H. Autoimmune-mediated polyneuropathy triggered by borrelial infection?. Muscle Nerve 2008, 37:781-785.
47. Rupprecht T., Plate A., Adam M., Wick M., Kastenbauer S., Schmidt C., Klein M., Pfister H., Koedel U. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J. Neuroinflammation 2009, 6:42.
48. Salomonsson S., Larsson P., Tengnér P., Mellquist E., Hjelmström P., Wahren-Herlenius M. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome. Scand. J. Immunol. 2002, 55:336-342.
49. Schneck S., Penn I. De-novo brain tumours in renal-transplant recipients. Lancet 1971, 1:983-986.
50. Sellebjerg F., Börnsen L., Khademi M., Krakauer M., Olsson T., Frederiksen J., Sørensen P. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Neurology 2009, 73:2003-2010.
51. Senel M., Rupprecht T., Tumani H., Pfister H., Ludolph A., Brettschneider J. The chemokine CXCL13 in acute neuroborreliosis. J. Neurol. Neurosurg. Psychiatry. 2009, doi:10.1136/jnnp.2009.195438.
52. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 2004, 14:164-174.
53. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Capello E., Mancardi G., Aloisi F. Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J. Neuropathol. Exp. Neurol. 2006, 65:124-141.
54. Smith J., Braziel R., Paoletti S., Lipp M., Uguccioni M., Rosenbaum J. Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. Blood 2003, 101:815-821.
55. Snider W., Simpson D., Aronyk K., Nielsen S. Primary lymphoma of the nervous system associated with acquired immune-deficiency syndrome. N Engl J. Med. 1983, 308:45.
56. Soto H., Wang W., Strieter R., Copeland N., Gilbert D., Jenkins N., Hedrick J., Zlotnik A. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc. Natl Acad. Sci. USA 1998, 95:8205-8210.
57. Stüve O., Marra C., Jerome K., Cook L., Cravens P., Cepok S., Frohman E., Phillips J., Arendt G., Hemmer B., Monson N., Racke M. Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann. Neurol. 2006, 59:743-747.
58. Takemura S., Braun A., Crowson C., Kurtin P., Cofield R., O'Fallon W., Goronzy J., Weyand C. Lymphoid neogenesis in rheumatoid synovitis. J. Immunol. 2001, 167:1072-1080.
59. Tun H., Personett D., Baskerville K., Menke D., Jaeckle K., Kreinest P., Edenfield B., Zubair A., O'Neill B., Lai W., Park P., McKinney M. Pathway analysis of primary central nervous system lymphoma. Blood 2008, 111:3200-3210.
60. Vassileva G., Soto H., Zlotnik A., Nakano H., Kakiuchi T., Hedrick J., Lira S. The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes. J. Exp. Med. 1999, 190:1183-1188.
61. Wekerle H., Sun D., Oropeza-Wekerle R.L., Meyermann R. Immune reactivity in the nervous system: modulation of T-lymphocyte activation by glial cells. J. Exp. Biol. 1987, 132:43-57.
62. Williams A., Wei H., Dave J., Tortella F. Acute and delayed neuroinflammatory response following experimental penetrating ballistic brain injury in the rat. J. Neuroinflammation 2007, 4:17.
63. Yoshida R., Imai T., Hieshima K., Kusuda J., Baba M., Kitaura M., Nishimura M., Kakizaki M., Nomiyama H., Yoshie O. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J. Biol. Chem. 1997, 272:13803-13809.
64. Yoshida R., Nagira M., Kitaura M., Imagawa N., Imai T., Yoshie O. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J. Biol. Chem. 1998, 273:7118-7122.
65. Yoshie O., Imai T., Nomiyama H. Novel lymphocyte-specific CC chemokines and their receptors. J. Leukoc. Biol. 1997, 62:634-644.
66. Zlotnik A., Morales J., Hedrick J. Recent advances in chemokines and chemokine receptors. Crit. Rev. Immunol. 1999, 19:1-47.